compounded glp 1 vs tirzepatide semaglutide Compound: Clinical Differences – PlexusDx Fridays | GLP-1 Telehealth Troubling Findings in Study of

Jefferies H, Coster J, Khalil A, Bot J, McCauley RD, Hall JC

Remedy Meds operates similarlyboth offer convenient GLP-1 access without in-person visits

Peptide therapy has become one of the most talked-about options for adults dealing with stubborn hormonal imbalance, and for good reason

In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)

Most side effects are mild and temporary, but some users may experience more serious reactions

Weiwer, M